| CRISPR Medicine | This is an overview of all our articles
A new regulatory framework proposed in February by the US Food and Drug Administration could dramatically reduce the time and cost of bringing...
A genome-wide CRISPR-Cas9 loss-of-function screening platform developed for primary human natural killer cells has identified several intracellular...
A new study from Stanford University combines CRISPR activation with single-cell and spatial approaches to identify mechanisms that enhance T...
A Chinese research team has developed TIGER (Template-Independent Genome Editing for Restoration), a CRISPR-Cas9 platform that corrects frameshift...
Some of the best links we picked up around the internet
Scribe Therapeutics is preparing to take its first cardiometabolic programme into the clinic in mid-2026, positioning STX-1150 as a potentially...
A hybrid CRISPR design pipeline improves the predictability of genome editing outcomes in mouse embryos. By favouring microhomology-mediated end...
